Global X Management Company’s AbbVie ABBV Stock Holding History

Global X Management Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$2.69M	Sell	29,007 -1,765	-6%	-$172K	0.05%	285
2018 Q1	$2.91M	Buy	30,772 +3,251	+12%	+$357K	0.06%	258
2017 Q4	$2.66M	Buy	27,521 +4,124	+18%	+$389K	0.06%	229
2017 Q3	$2.08M	Buy	23,397 +1,172	+5%	+$89.2K	0.06%	241
2017 Q2	$1.61M	Buy	22,225 +2,693	+14%	+$181K	0.05%	257
2017 Q1	$1.27M	Buy	19,532 +3,446	+21%	+$217K	0.05%	286
2016 Q4	$1.01M	Buy	16,086 +4,019	+33%	+$245K	0.04%	289
2016 Q3	$761K	Buy	12,067 +10,639	+745%	+$689K	0.03%	292
2016 Q2	$88K	Buy	1,428 +1,207	+546%	+$73.5K	﹤0.01%	562
2016 Q1	$13K	Sell	221 -64	-22%	-$3.57K	﹤0.01%	841
2015 Q4	$17K	Sell	285 -19	-6%	-$1.09K	﹤0.01%	516
2015 Q3	$17K	Sell	304 -45	-13%	-$2.93K	﹤0.01%	508
2015 Q2	$23K	Buy	349 +59	+20%	+$3.85K	﹤0.01%	478
2015 Q1	$17K	Sell	290 -39	-12%	-$2.36K	﹤0.01%	513
2014 Q4	$22K	Buy	329 +82	+33%	+$5.17K	﹤0.01%	444
2014 Q3	$14K	Sell	247 -82	-25%	-$4.55K	﹤0.01%	522
2014 Q2	$19K	Hold	329	–	–	﹤0.01%	517
2014 Q1	$17K	Sell	329 -150	-31%	-$7.58K	﹤0.01%	518
2013 Q4	$25K	Hold	479	–	–	﹤0.01%	389
2013 Q3	$21K	Sell	479 -48	-9%	-$2.13K	﹤0.01%	385
2013 Q2	$22K	Buy	+527	New	+$23K	﹤0.01%	358

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Global X Management Company's ABBV Position: Q2 2018 in Review

Global X Management Company reduced its AbbVie (ABBV) stake by 5.7% in Q2 2018, selling an estimated $172K and leaving 29,007 shares worth $2.69M. The position accounts for 0.05% of the portfolio, ranked #285.

Global X Management Company first reported a position in ABBV in Q2 2013 and has held it in 21 quarters since. The position peaked at $2.91M in Q1 2018. 1,996 funds tracked by Wall St. Rank hold ABBV as of Q2 2018.

Global X Management Company held 29,007 shares of AbbVie worth $2.69M as of Q2 2018.
Global X Management Company sold 1,765 AbbVie shares in Q2 2018, an estimated $172K.
AbbVie made up 0.05% of Global X Management Company's portfolio in Q2 2018, its #285 holding.
Global X Management Company first reported a position in AbbVie in Q2 2013 and has held it in 21 quarters since.
Global X Management Company's AbbVie position peaked at $2.91M in Q1 2018.
1,996 funds tracked by Wall St. Rank held AbbVie as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.